Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Pro Medicus Limited ( (AU:PME) ) has shared an announcement.
Pro Medicus director Anthony Barry Hall has increased his direct shareholding in the company through an on-market trade. Hall acquired 8,500 ordinary shares at $110.13 per share via Research Corporation Pty Ltd as trustee for the Anthony Hall Family Trust.
Following the purchase, Hall’s total relevant interest in Pro Medicus has risen from 24,148,520 to 24,157,020 ordinary shares across several entities. The incremental increase underlines ongoing insider alignment with shareholders, though it does not materially alter the company’s overall capital structure.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$128.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited is a healthcare technology company focused on medical imaging software and services. The company provides radiology and imaging IT solutions, with its shares listed on the Australian Securities Exchange, and its shareholder base includes directors and associated entities.
Average Trading Volume: 306,009
Technical Sentiment Signal: Hold
Current Market Cap: A$12.85B
Learn more about PME stock on TipRanks’ Stock Analysis page.